Moolec Science announces closing of business combination

Moolec Science (MLEC) announced the successful closing of its previously announced strategic business combination with Bioceres Group, Gentle Technologies, and Nutrecon. With the closing, Moolec emerges as the parent company of a significantly expanded and enhanced enterprise at the forefront of sustainable life sciences and food-tech innovation. This transformative transaction brings together complementary capabilities across food ingredients, ag-biologicals, precision fermentation, biomaterials, and R&D services, consolidating Moolec’s position as a differentiated life science platform focused on sustainable solutions from molecule to ingredient. The Business Combination, initially announced on April 17, 2025, was ratified by Moolec shareholders at the Extraordinary General Meeting held on June 16, with ~77% of the outstanding shares present at the meeting, and ~98% of the votes cast were in favor of the transaction. Under the terms of the transaction, Bioceres Group shareholders have exchanged their equity ownership for approximately 6.9 million shares of Moolec. The shareholders of 100% of Nutrecon and 50% of Gentle Tech have received, in exchange for their ownership in these entities, approximately 0.65 million shares of Moolec and 0.5 million Moolec private warrants, each with a strike price of $20.00. The combined company will continue operating under the name Moolec Science, with its securities trading on NASDAQ under the ticker symbols “MLEC” and “MLECW”. The Board of Directors has appointed Mr. Alejandro Antalich as CEO of Moolec Science.